<VariationArchive VariationID="2440094" VariationName="NM_000082.4(ERCC8):c.427del (p.Thr143fs)" VariationType="Deletion" Accession="VCV002440094" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-06" DateCreated="2023-03-05" MostRecentSubmission="2024-04-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2407444" VariationID="2440094">
      <GeneList>
        <Gene Symbol="ERCC8" FullName="ERCC excision repair 8, CSA ubiquitin ligase complex subunit" GeneID="1161" HGNC_ID="HGNC:3439" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="60866454" stop="60945070" display_start="60866454" display_stop="60945070" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="60169658" stop="60240904" display_start="60169658" display_stop="60240904" Strand="-" />
          </Location>
          <OMIM>609412</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000082.4(ERCC8):c.427del (p.Thr143fs)</Name>
      <CanonicalSPDI>NC_000005.10:60904845:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="60904846" stop="60904846" display_start="60904846" display_stop="60904846" variantLength="1" positionVCF="60904845" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="60200673" stop="60200673" display_start="60200673" display_stop="60200673" variantLength="1" positionVCF="60200672" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>T143fs</ProteinChange>
      <ProteinChange>T85fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.60904848del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.60904848del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.60200675del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.60200675del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009289.1" sequenceAccession="NG_009289" sequenceVersion="1" change="g.45233del">
            <Expression>NG_009289.1:g.45233del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000082.3" sequenceAccession="NM_000082" sequenceVersion="3" change="c.425delA">
            <Expression>NM_000082.3:c.425delA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000073.1" sequenceAccession="NP_000073" sequenceVersion="1" change="p.Thr143Glnfs">
            <Expression>NP_000073.1:p.Thr143Glnfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000082.4" sequenceAccession="NM_000082" sequenceVersion="4" change="c.427del" MANESelect="true">
            <Expression>NM_000082.4:c.427del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000073.1" sequenceAccession="NP_000073" sequenceVersion="1" change="p.Thr143fs">
            <Expression>NP_000073.1:p.Thr143fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007233.3" sequenceAccession="NM_001007233" sequenceVersion="3" change="c.253del">
            <Expression>NM_001007233.3:c.253del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007234.1" sequenceAccession="NP_001007234" sequenceVersion="1" change="p.Thr85fs">
            <Expression>NP_001007234.1:p.Thr85fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007234.3" sequenceAccession="NM_001007234" sequenceVersion="3" change="c.427del">
            <Expression>NM_001007234.3:c.427del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007235.1" sequenceAccession="NP_001007235" sequenceVersion="1" change="p.Thr143fs">
            <Expression>NP_001007235.1:p.Thr143fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001290285.2" sequenceAccession="NM_001290285" sequenceVersion="2" change="c.23-1130del">
            <Expression>NM_001290285.2:c.23-1130del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_466" sequenceAccession="LRG_466">
            <Expression>LRG_466:g.45233del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_466t1" sequenceAccession="LRG_466t1">
            <Expression>LRG_466t1:c.427del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000082.4(ERCC8):c.427del (p.Thr143fs) AND not provided" Accession="RCV003144994" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000082.4(ERCC8):c.427del (p.Thr143fs) AND Cockayne syndrome type 1" Accession="RCV003989821" Version="1">
        <ClassifiedConditionList TraitSetID="439">
          <ClassifiedCondition DB="MedGen" ID="C0751039">Cockayne syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-03-05" MostRecentSubmission="2024-04-06">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2024-04-03">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="439" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1523" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome type A</ElementValue>
                <XRef ID="Cockayne+Syndrome/1701" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome classical</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome classic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 1</ElementValue>
                <XRef ID="MONDO:0019569" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSA</ElementValue>
                <XRef Type="MIM" ID="216400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ERCC8</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1415" />
                <XRef ID="1415" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90321" DB="Orphanet" />
              <XRef ID="C0751039" DB="MedGen" />
              <XRef ID="MONDO:0019569" DB="MONDO" />
              <XRef Type="MIM" ID="216400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7136420" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="d05b96f4a0930cd0a37fbb377c5eb824dad547475077ebbb92ec3643cf796021|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003830684" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000082.3:c.427del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8987463" SubmissionDate="2024-03-26" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_000082.4:c.427del|OMIM:216400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004807110" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000082.4:c.427del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="216400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14340315</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8987463" TraitType="Disease" MappingType="XRef" MappingValue="216400" MappingRef="OMIM">
        <MedGen CUI="C0751039" Name="Cockayne syndrome type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7136420" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

